Author: Chen, Yongxiong; Chan, Vera Sau-Fong; Zheng, Bojian; Chan, Kelvin Yuen-Kwong; Xu, Xiaoning; To, Leo Yuk-Fai; Huang, Fang-Ping; Khoo, Ui-Soon; Lin, Chen-Lung Steve
Title: A novel subset of putative stem/progenitor CD34(+)Oct-4(+) cells is the major target for SARS coronavirus in human lung Document date: 2007_10_29
ID: u4qhk802_14_1
Snippet: ed labeling, one indicated by a white arrow in m; also visible in n and p), followed by FISH for ACE2 (green labeling, some indicated by green arrows in n) and ISH for L-SIGN (purple labeling, some indicated by pink arrows in p). DAPI counterstaining is in q. Some of the ACE2 Ï© CD34 Ï© Oct4 Ï© L-SIGN Ï© cells are close to surfactant A Ï© cells (g and k) or cytokeratin Ï© cells (p). Panels of each row represent results on the same section of a pa.....
Document: ed labeling, one indicated by a white arrow in m; also visible in n and p), followed by FISH for ACE2 (green labeling, some indicated by green arrows in n) and ISH for L-SIGN (purple labeling, some indicated by pink arrows in p). DAPI counterstaining is in q. Some of the ACE2 Ï© CD34 Ï© Oct4 Ï© L-SIGN Ï© cells are close to surfactant A Ï© cells (g and k) or cytokeratin Ï© cells (p). Panels of each row represent results on the same section of a patient. Results are representative of eight patients with lung cancer. Bar, 20 m. (B) Fresh lung tissues resected from cancer patients were cut into small blocks, exposed to SARS-CoV for 16 h, and studied by IHC for surfactant A (brown labeling in a and b, one indicated by a yellow arrow in b; also visible in e), for SARS antigen (red labeling, indicated by a red arrow in b; also visible in c), followed by FISH for CD34 (green expressed both CD34 and Oct-4 ( Fig. 3 B , d and e, green and purple, respectively, and Fig. S8 ). In separate sections, triplecolor staining confi rmed that no cytokeratin or surfactant expression was colocalized with SARS antigen (Fig. S9) .
Search related documents:
Co phrase search for related documents- brown labeling and green arrow: 1
- brown labeling and green labeling: 1, 2
- brown labeling and Ï© cell: 1
- brown labeling and IHC study: 1
- brown labeling and lung cancer: 1, 2
- cancer patient and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cancer patient and lung cancer patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- dapi counterstaining and green arrow: 1
- dapi counterstaining and green labeling: 1, 2
- dapi counterstaining and Ï© cell: 1
- dapi counterstaining and IHC study: 1
- dapi counterstaining and lung cancer: 1, 2
- green arrow and Ï© cell: 1
- green arrow and IHC study: 1
- green arrow and lung cancer: 1
- green labeling and Ï© cell: 1
- green labeling and IHC study: 1
- green labeling and lung cancer: 1, 2, 3
- Ï© cell and IHC study: 1
Co phrase search for related documents, hyperlinks ordered by date